Hiperplasia endometrial

Kistner RW ., Hammond CH.B., Kaufman RH. MenopauseCourse. Sylabus of the American Fertility Society. XI Annual postgraduate course, Houston Texas, 1980; 19: 7.

Schiff I., Sela HK., Cramer D., Tulchinsky D., Ryan K. Endometrial hyperplasia in women on cyclic or continuous estrogen regimens. Fertil Steril 1982; 37: 79.

Scully RE. Definición de las alteraciones precursoras del carcinoma endometrial. Clínicas Obstétricas y Ginecológicas de Norteamérica. Editorial Interamericana 1982; 41-63.

Gusberg SB. Precursors corpus carcinoma: Estrogens and adenomatous hyperplasia. Am, J. Obstet. Gynecol. 1947; 54: 905.

Hertig AT., Somrners SC. Genesis of endometrial cancer. I study of prior biopsies. Cancer 1949; 2: 946.

Vellios F., Endometrial hyperplasia and carcinoma in situ. Gynecol. Oncol. 1974; 2: 152.

Sommers SC., Hertig A T., Bengaloff H. Genesis of endometrial carcinoma: 11 cases 19-35 years o1d. Cancer 1949; 2: 957.

Gusberg SB., Chen SY. and Cohen CJ. Endometrial Cancer: Factors influencing the chaise of treatment. Gynecol. Oncol. 1974; 2: 308.

Wentz WB. Treatment of persistent endometrial hyperplasia with progestins. Am. J. Obstet. Gynecol. 1966; 96: 999.

Sherman AI. and Brown S. The precursors of endometrial carcinoma. Am. J. Obstet. Gynecol. 1979; 135: 947.

Lifshitz S., Buchsbaum HJ. Diagnosis and staging of endometrial carcinoma. Posgraduate Obstetrics and Gynecology. 1983; 3: 1.

Gambrell RD., Bagnell CA., Greenblatt RB. Role of estrogens and progesterone in the etiology and prevention of endometrial cancer: Review. Am. J. Obstet. Gynecol. 1983; 146: 696.

Cramer DW., Knapp RC. Review of epidemiologic studies of endometrial cancer and exogenous estrogens. Obstet. Gynecol. 1979; 54: 521.

Henderson BE. The cancer question: an overview of recent epidemiologic and retrospective data. Am. J. Obstet. Gynecol. 1989; 161: 1859.

Bhagavan B., Parmley TH., Rosenshen NB., Jefferys J., GrissoJ., Stolley P. Comparison of estrogen-induced hyperplasia to endometrial carcinoma Obstet. Gynecol.1984 64: 12.

Hammond CB., Maxon WS. Current status of estrogen therapy for the menopause. Fertil Steril 1982; 37: 5.

O'Malley B.W. Mechanisms of action of steroid hormones. N. Engl. J. Med. 1971; 284: 370.

King RJB., Whiteheal MI., Campbell S. Effect of estrogen and progestin treatments on endometrium from postmenopausal women. Cancer Res 1979; 39: 1094.

King RJB., Dyer G., Collins WP. Intracellular estradiol, estrone and estrogen receptor levels in endometria from posmenopausal women receiving estrogens and progestins. J. Steroid Biochem 1980; 13: 337.

Mac Laughlin DT. and Richarson GS. Progesterone binding by normal and abnormal human endometrium. J. Clin. Endocrinol. Metab. 1976; 52: 667.

Tavassoli F., Kraus FT. Endometrial lesions in uteri resected for atypical endometrial hyperplasia. Am. J. Clin. Pathol. 1978; 70: 770.

Kurman RJ., Kaminski PF., Norris HJ. The behavior of endometrial hyperplasia. Cancer 1985; 56: 403.

Ferenczy A., Gelfand M. The biologic significance of cytologic atypia in progestogen-treated endometrial hyperplasia. Am. J. Obstet. Gynecol. 1989; 160: 126.

Moreno-Escallón B., Angula A., Botero LF., Restrepo P. Manejo de la hiperplasia endometrial con acetato de medroxiprogesterona de depósito. Rev. Col. Obstet. Ginecol. 1991 ; 42: 63.

Nasri MN., Shepard JH., Setchell ME., Lowe DG., Chard T. The role of vaginal sean in measurement of endometrial thickness in postmenopausal women. Br. J. Obste!. Gynecol. 1991; 98: 470.

Malpani A., Singer J., Wolverson MK., Merenda G. Endometrial hyperplasia: value of endometrial thickness in ultrasonographic diagnosis and clinical significance. J. Clin. Ultrasound. 1990; 18: 173.

Osmer R., Volksen M., Schaner A. Vaginosography for early detection of endometrial carcinoma. Lancet. 1990; 335: 1569.

Lin CM., Gonsink BB., Wolf IS ., Feldesman RM., Stuenkel AC., Braly SP., Pretorius HD.: Endometrial thickess after menopause: Effect of hormone replacement. Radiology 1991; 180: 427.

Tsionou C., Minaretzis D., Papageorgiou I., Nakopoulou L., Michalas S., Aravantinos D. Expression of carcino embryonic antigen and feritin in normal, hyperplastic and neoplastic endometrium. Gynecol. Oncol. 1991; 4 1: 193.

Neunteufel W., Breitenecker G. CA 19-9, CA 125 and CEA in the endometrial mucosa during the mestrual cycle in atypical hyperplasia and endometrial carcinoma. Cancer-Lett 1989; 48: 77.

Panici PB., Scambia G., Baiocchi G., Perrone L., Greggi S., Battaglia F., Mancuso S. Multiple serum markers in patients with endometrial cancer. Gynecol. Obstet. Invest. 1989; 27: 208.

Laurie M., Elmalach l., Weill S. The patterm of epithelial mucin secretion in normal hyperplastic and adenocarcinomatous endometrium. Gynecol. Oncol. 1988; 30: 274.

Bergeron C., Ferency A., Shyamala G. Distribution of estrogen receptors in various cell types of normal hiperplastic and neoplastic human endometrial tissues. Lab. Invest. 1988; 58: 338.

Iversen OE. Flow cytometric deoxy ribonucleic acid index: A prognostic factor in endometrial carcinoma. Am. J. Obstet. Gynecol. 1986; 155:770.

Kysela B., Siracky J., Redecha M., Bardos A. Flow cytometry analysis of endometrial hyperplasia and carcinoma. Neoplasma. 1990; 37: 489.

Kelly RM. In proceeding of the Second Conference of Steroids and Cancer, council of pharmacy and chemistry, American Medical Association, Chicago 1951; 116.

Kistner RW. Histological effects of progestins on hyperplasia and carcinoma in situ of the endometrium. Cancer 1959; 12: 1106.

Eichner E., Abellera M. Endometrial hyperplasia treated by progestins. Obstet. Gynecol. 1971; 38: 739.

Wellenback DL., Rakoff AE. Hyperplasia of the endometrium. J. Albert Einsten Med. Center. 1953; 2: 3.

Kelley RW., Baker WH. Effects of 17 alpha hydroxyprogesterone caproate on metastasic endometrial cancer. Conference on experimental clinical cancer chemotherapy, monograph 9, Bethesda, National Cancer Institute, 1965; 235.

Gal D., Edman CD., Vellios F., Forney J. Long-term effect of megestrol acetate in the treatment of endometrial hyperplasia. Am. J. Obstet. Gynecol. 1983; 146: 316.

Hsueh AJW., Peck EJ., Clark JH. Progesterone antagonism of the estrogen receptor and estrogen induced uterine growth. Nature 1975; 254: 337.

Tseng L., Gurpide E. Effect of progestins on estradiol receptor Ievels in human endometrium. J. Clin. Endocrino! Metab. 1975; 41 : 402.

Kokko E., Janne 0 ., Kauppila A., Vihko R. Effects of tamoxifen, medroxiprogesterone acetate and their combination on human endometrial estrogen and progestin receptor concentrations, 17 betahydroxysteroid dehydrogenase activity and serum hormone concentrations. Am. J. Obstet. Gynecol. 1982; 143: 382.

Clark JH., Anderson JN., Peck EJ. Estrogen receptor anti-estrogen complex: Atypical binding by uterine nuclei and effects on uterine growth. Steroids. 1974; 22: 707.

Friedrich ER., Meyer JS. Estrogen-progestin pharmacodynamics of the postmenopausal endometrium studied by thymidine labe1ing. Am. J. Obstet. Gynecol. 1982; 143: 352.

Jasonni VM., Bulletti C., Balducci, Naldi S., Martinelli G., Galassi A., Flamigni C. The effect of progestin on factors influencing growth and invasion of the endometrial carcinoma. Ann. N.Y. Acad. Sci. 1991 ; 622: 463.

Moreno-Escallón B. Inductores de ovulación. Universitas Médica 1989; 30:6.

Bulletti C.,Jasonni U.M., Tabanellis., Balduca M., Fuschini G., Flamigni C. Danazol reverses endometrial hyperplasia to normal endometrium. Acta Eur Fertil 1987; 18: 185.

Scarselli G., Tantini C., Colafranceschi M., Taddei GL., Bargelli G., Venturini N., Branconi F. Levonorgestrel nova T and precancerous lesions of the endometrium. Eur J. Gynecol. Oncol. 1988; 9: 284.

De Cherney A., Diamond MP., Lavy G. Endometrial ablation for intractable uterine bleeding: Hysteroscopic resection. Obstet. Gynecol.1987; 70: 668.

Loffer FD. Hysteroscopic endometrial ablation with the Nd: Y AG laser using a non-touch technique. Obstet. Gynecol. 1987; 69: 679.

Hanna JH., Major MC., Brady KW., Hill JM., Phillips LG. Detection of postmenopausal women at risk for endometrial carcinoma by a progesterone challange test. Am. J. Obstet. Gynecol. 1983; 147: 872.